首页> 外文期刊>Hawai i Journal of Medicine & Public Health: A journal of Asia Pacific medicine & public health >Albuminuria as a Marker of Cardiovascular Risk in HIV-Infected Individuals Receiving Stable Antiretroviral Therapy
【24h】

Albuminuria as a Marker of Cardiovascular Risk in HIV-Infected Individuals Receiving Stable Antiretroviral Therapy

机译:蛋白尿是接受稳定的抗逆转录病毒疗法的HIV感染者心血管风险的标志

获取原文
       

摘要

Albuminuria (urinary excretion of more than 30 milligram of albumin per gram of creatinine) serves as an indicator of microvascular injury, which has been associated with atherosclerosis and cardiovascular disease in HIV-seronegative individuals. Albuminuria has been reported to be prevalent among HIV-seropositive individuals, however, the relationship between albuminuria and risk for cardiovascular disease in this population has not been well-studied. We examined the relationships between albuminuria and parameters of atherosclerosis including carotid intima-media thickness and traditional cardiovascular risk assessment among HIV-seropositive individuals receiving stable antiretroviral therapy. We utilized a cross-sectional baseline data from the Hawai‘i Aging with HIV-Cardiovascular Study cohort.
机译:蛋白尿(每克肌酐尿中排泄的尿蛋白超过30毫克)可作为微血管损伤的指标,该损伤与HIV血清反应阴性的人的动脉粥样硬化和心血管疾病有关。据报道,蛋白尿在艾滋病毒血清阳性人群中普遍存在,但是,尚未对该人群中蛋白尿与心血管疾病风险之间的关系进行深入研究。我们检查了接受稳定抗逆转录病毒治疗的HIV血清阳性个体中白蛋白尿与动脉粥样硬化参数(包括颈动脉内膜中层厚度)和传统心血管风险评估之间的关系。我们利用了来自夏威夷衰老与HIV心血管研究队列的横断面基线数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号